| | Identification | Back Directory |  | [Name] 
 10,13-dimethyl-17-oxo-3-sulfooxy-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene
 |  | [CAS] 
 651-48-9
 |  | [Synonyms] 
 Formylisoglutamic acid
 Abiraterone Impurity 73
 Abiraterone Impurity 54
 Dehydroepiandrosterone Sulfate
 DEHYDROEPIANDROSTERONESULPHATE
 (3β)-3-(Sulfooxy)androst-5-en-17-one
 Androst-5-en-17-one, 3-(sulfooxy)-, (3β)-
 DHEA Sulfate
DISCONTINUED. Please see S673250
 Prasterone Sulfate Sports Nutrition Supplements Prasterone Sodium Sulfate 651-48-9
 10,13-dimethyl-17-oxo-3-sulfooxy-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene
 10,13-dimethyl-17-oxo-3-sulfooxy-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene USP/EP/BP
 [(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] hydrogen sulfate
 sulfuric acid [(3S,8R,9S,10R,13S,14S)-17-keto-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] ester
 |  | [Molecular Formula] 
 C19H28O5S
 |  | [MDL Number] 
 MFCD00242651
 |  | [MOL File] 
 651-48-9.mol
 |  | [Molecular Weight] 
 368.49
 | 
 | Chemical Properties | Back Directory |  | [Melting point ] 
 190-192 °C
 |  | [Boiling point ] 
 468.81°C (rough estimate)
 |  | [density ] 
 1.1763 (rough estimate)
 |  | [refractive index ] 
 1.5300 (estimate)
 |  | [form ] 
 Solid
 |  | [pka] 
 -3.51±0.18(Predicted)
 |  | [color ] 
 White to off-white
 | 
 | Hazard Information | Back Directory |  | [Uses] 
 Dehydroepiandrosterone sulfate, a neuroactive neurosteroid, plays a major role in brain development and aging by influencing the migration of neurons, arborization of dendrites, and formation of new synapses[1][2][3].
 |  | [Definition] 
 ChEBI: A steroid sulfate that is the 3-sulfooxy derivative of dehydroepiandrosterone.
 |  | [in vivo] 
 
 DHEAS chronic administration produces a dose-dependent effect on performance[3].
 | Animal Model: | Sixty-four male Sprague-Dawley rats, approximately 90 days of age (300-400 g)[3]. |  | Dosage: | 5, 10, or 20 mg/kg. |  | Administration: | Subcutaneous injection starting 7 days post-surgery and 1 h prior to all behavioral testing. |  | Result: | Significantly effective in improving latency to reach the platform as compared to injured rats receiving vehicle. | 
 |  | [IC 50] 
 Human Endogenous Metabolite
 |  | [References] 
 [1] E E Baulieu, et al. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4089-91. DOI:10.1073/pnas.95.8.4089
 [2] C R Parker Jr, et al. Dehydroepiandrosterone and dehydroepiandrosterone sulfate production in the human adrenal during development and aging. Steroids. 1999 Sep;64(9):640-7. DOI:10.1016/s0039-128x(99)00046-x
 [3] Stuart W Hoffman, et al. The delayed administration of dehydroepiandrosterone sulfate improves recovery of function after traumatic brain injury in rats. J Neurotrauma. 2003 Sep;20(9):859-70. DOI:10.1089/089771503322385791
 | 
 | 
                    
                        
                            | Company Name: | Rhawn Reagent |  
                            | Tel: | 400-400-1332688 18019345275 |  
                            | Website: | http://www.rhawn.cn |  |